Elpiscience and Astellas enter into research collaboration and license agreement
Elpiscience Biopharma, Ltd. and Astellas Pharma Inc. recently announced a research collaboration and license agreement for novel bi-specific macrophage engagers, ES019 and another program. The two companies will collaboratively conduct early-stage research for these two programs. Elpiscience will also grant Astellas the right to add up to two additional programs to be included in the […]
CRO company TriApex completes Series C financing round led by Legend Capital
TriApex Laboratories Co., Ltd recently announced the completion of its Series C financing round, which was led by Legend Capital. This funding milestone will help TriApex continue to lead in the field of special diseases and devote itself to providing non-clinical data with more clinical value, accelerating the international expansion of integrated R&D services from […]
Ultivue enters multiple partnerships for advanced mIF and AI in translational science
Ultivue, Inc., an industry leader in multiplexing assays and analytics solutions for tissue biomarker studies, recently announced multiple collaborations for AI-powered spatial phenomics solutions for translational research groups and Biopharma. Ultivue develops unique workflows for use in both multiplex immunofluorescence (mIF) imaging and spatial phenomics. Its proprietary InSituPlex® technology is designed for fast and comprehensive […]
